» Articles » PMID: 35111152

Exhausted and Apoptotic BALF T Cells in Proinflammatory Airway Milieu at Acute Phase of Severe Mycoplasma Pneumoniae Pneumonia in Children

Overview
Journal Front Immunol
Date 2022 Feb 3
PMID 35111152
Authors
Affiliations
Soon will be listed here.
Abstract

Severe mycoplasma pneumoniae pneumonia (MPP) in children presents with serious clinical complications. Without proper and prompt intervention, it could lead to deadly consequences. Dynamics of the inflammatory airway milieu and activation status of immune cells were believed to be the hallmark of the pathogenesis and progress of the disease. In this study, by employing the T-cell sorting and mRNA microarray, we were able to define the main feature of the chemokine/cytokine expression and the unique characteristics of T cells in the bronchoalveolar lavage fluid (BALF) from severe MPP patients at acute phase. Our study for the first time delineated the molecular changes in isolated BALF T cells in severe MPP children with respect to the cytokine/chemokine expression, cell activation, exhaustion, and apoptosis. By comparing the BALF aqueous expression of cytokines/chemokines with that in sorted T cells, our data give a preliminary clue capable of finishing out the possible cell source of the proinflammatory cytokines/chemokines from the BALF mixture. Meanwhile, our data provide a distinctively pellucid expression profile particularly belonging to the isolated BALF T cells demonstrating that in the inflammatory airway, overactivated T cells were exhausted and on the verge of apoptotic progress.

Citing Articles

Association of serum interleukin-17 level and pneumonia in children: a systematic review and meta-analysis.

Leerach N, Sitthisak S, Kitti T, Teerawattanapong N, Mahikul W, Lamlertthon S Transl Pediatr. 2024; 13(9):1588-1599.

PMID: 39399709 PMC: 11467231. DOI: 10.21037/tp-24-218.


Study on the Correlation Between the Expression of NF-Ƙb in the Alveolar Lavage Fluid of Children with Severe Mycoplasma Pneumoniae Pneumonia, Its Clinical Characteristics, and Cellular Immunity.

Ding X, Li S, Liu X, Zhan X, Wang Z, Wang M Infect Drug Resist. 2024; 17:2469-2484.

PMID: 38915319 PMC: 11194830. DOI: 10.2147/IDR.S411361.


Predictive value of chemokines (CCL 2) in bronchoalveolar lavage fluid for refractory mycoplasma pneumonia in children.

Zhu J, Liu X, Zhan X, Wang M, Zhang Y, Na L Ital J Pediatr. 2023; 49(1):125.

PMID: 37740208 PMC: 10517484. DOI: 10.1186/s13052-023-01528-2.


Unveiling the stealthy tactics: mycoplasma's immune evasion strategies.

Wang J, Liang K, Chen L, Su X, Liao D, Yu J Front Cell Infect Microbiol. 2023; 13:1247182.

PMID: 37719671 PMC: 10502178. DOI: 10.3389/fcimb.2023.1247182.


miRNA, lncRNA and circRNA: targeted molecules with therapeutic promises in Mycoplasma pneumoniae infection.

Gan T, Yu J, He J Arch Microbiol. 2023; 205(8):293.

PMID: 37477725 DOI: 10.1007/s00203-023-03636-3.


References
1.
Xu P, Zhang F, Chang M, Zhong C, Sun C, Zhu H . Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury. J Neuroinflammation. 2021; 18(1):64. PMC: 7927238. DOI: 10.1186/s12974-021-02115-0. View

2.
Saraya T, Kurai D, Nakagaki K, Sasaki Y, Niwa S, Tsukagoshi H . Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications. Front Microbiol. 2014; 5:410. PMC: 4127663. DOI: 10.3389/fmicb.2014.00410. View

3.
Rivino L, Gruarin P, Haringer B, Steinfelder S, Lozza L, Steckel B . CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function. J Exp Med. 2010; 207(3):565-77. PMC: 2839148. DOI: 10.1084/jem.20091021. View

4.
Jin X, Zhu Y, Zhang Y, Chen J, Rong L, Zhao X . Assessment of levels of D-dimer and interferon-γ in pediatric patients with pneumonia and its clinical implication. Exp Ther Med. 2018; 16(6):5025-5030. PMC: 6256836. DOI: 10.3892/etm.2018.6873. View

5.
Matsuo K, Kitahata K, Kawabata F, Kamei M, Hara Y, Takamura S . A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8 T Cells. Front Immunol. 2018; 9:2775. PMC: 6277777. DOI: 10.3389/fimmu.2018.02775. View